presents

Lung Cancer Review 2017 Webinar

In honor of November Lung Cancer Awareness Month

AGENDA

Monday, November 20, 2017

5:30pm   -   Welcome Remarks                                         

                      Dr. Gilberto Lopes

 

5:35pm   -   What’s New in Systemic Treatments  - Part I      

                      Dr. Raja Mudad

                   

5:50pm   -   What’s New in Systemic Treatments - Part II       

                     Dr. Gilberto Lopes

                     

6:05pm    -  Review of Minimally Invasive  -Surgery Techniques in Lung  Cancer

                     Dr. Nestor Villamizar

                      

6:20pm    -   Questions & Answers 

 

 

Meet the Distinguished Speakers

Dr. Gilberto Lopes, a medical oncologist, is the medical director for international programs and associate director Global Oncology at the University of Miami Sylvester Comprehensive Cancer Center and associate professor at the Miller School of Medicine; and associate editor for ASCO University and for the society’s Journal of Global Oncology; he previously worked at the Johns Hopkins University and was chief medical and scientific officer for the Oncoclinicas Group, the largest oncology provider in Latin America with 35 clinics and more than 300 oncologists in nine states in Brazil.

 

Dr. Lopes has published more than 100 papers in journals such as the Journal of Clinical Oncology, Cancer, Nature Reviews, Lancet, Lancet Oncology and Health Affairs. In addition to delivering lectures around the world, he has been principal, co-Principal Investigator or steering committee member in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary and thoracic cancers. His other main areas of research interest are health economics, value, policy and access to cancer drugs and treatment in low and middle income countries. 

 

Dr. Lopes is currently a committee member for the International Association for the Study of Lung Cancer (IASLC), a member of the European Society of Medical Oncology expensive, innovative Medicines working group and the chair the international clinical trials workshop working group and track leader global health at the American Society of Clinical Oncology (ASCO), as well as an executive board member the Latin American Cooperative Oncology Group (LACOG). 

 

o served as an expert for the International Atomic Energy Agency, the World Health Organization and the Pan-American Health Organization and advised governments, professional societies and industry on issues related to cancer control and treatment in low- and middle-income countries.

Dr. Raja Mudad, received his B.S. Biology with high distinction in 1985 and his M.D. in 1989 from the American University of Beirut. He completed an internship and residency in 1992 in Internal Medicine and a fellowship in Hematology and Medical Oncology in 1995 at Duke University Medical Center in Durham, North Carolina. In 1995 Dr.  joined the Tulane University faculty as in Medicine in the Section of Hematology and Medical Oncology. He was promoted to Assistant Professor of Medicine in 1996 and in July of 2001 to the rank of Associate Professor of Medicine. In 1996 Dr. was appointed Chief of the Section of Hematology/Oncology at the Veterans Administration Medical Center in New Orleans and was also the Associate Chief, Section of Hematology and Medical Oncology at Tulane Medical School and Director of Hematology/Oncology Fellowship Training between 2001-2006. Dr Mudad's primary interest and research in the field of solid tumor oncology and specifically lung cancer. He has conducted several clinical trials in lung, prostate, head & neck and bladder cancers.

Dr. Nestor Villamizar, obtained his MD degree from Pontificia Universidad Javeriana in Bogota, Colombia, recognized as one of the leading centers in the country.  His postgraduate education included three years of research in surgery at Duke University Medical Center where he also completed his residency in general surgery.  He further specialized in thoracic surgery at the Brigham and Women’s Hospital, Harvard Medical School.  His training included all aspects of general thoracic surgery: tumors of the lung, esophagus, airway, pleura, chest wall and mediastinum, paraesophageal hernias, anti-reflux surgery and esophageal motility disorders.  Dr.   is a member of the Society of Thoracic Surgeons. His research has been presented at several national meetings, and he has numerous publications in high impact journals.  He is fluent in English and Spanish.  He currently works as an Assistant Professor of Surgery and is on staff at the University of Miami Hospital, Sylvester Cancer Comprehensive Center, Jackson Memorial Hospital and Miami VA hospital.  His main interest is minimally invasive thoracic surgery.